{
 "url": "https://etfiq.com/funds/ibrn/holdings/",
 "section": "funds",
 "title": "IBRN Holdings: All 69 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 69 IBRN holdings with weights, as of Oct 13, 2026. The top 3 are BIIB 5.28%, NBIX 4.43% and PTCT 4.40%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "IBRN",
 "fund": "iShares Neuroscience and Healthcare ETF",
 "fund_page": "https://etfiq.com/funds/ibrn",
 "positions": 69,
 "positions_listed_on_page": 69,
 "lead": "IBRN held 69 positions as of Oct 13, 2026. Biogen is the largest at 5.28%; the top 10 are 41.3% of the fund.",
 "source": {
  "name": "iShares (BlackRock)",
  "url": "https://www.ishares.com/us/products/329137/x/latest-holdings.csv",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Biogen",
   "ticker": "BIIB",
   "weight_pct": 5.28,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 2,
   "holding": "Neurocrine Biosciences",
   "ticker": "NBIX",
   "weight_pct": 4.43,
   "page": "https://etfiq.com/holdings/nbix/"
  },
  {
   "rank": 3,
   "holding": "PTC Therapeutics",
   "ticker": "PTCT",
   "weight_pct": 4.4,
   "page": "https://etfiq.com/holdings/ptct/"
  },
  {
   "rank": 4,
   "holding": "Alkermes",
   "ticker": "ALKS",
   "weight_pct": 4.39,
   "page": "https://etfiq.com/holdings/alks/"
  },
  {
   "rank": 5,
   "holding": "Edgewise Therapeutics",
   "ticker": "EWTX",
   "weight_pct": 4.29,
   "page": null
  },
  {
   "rank": 6,
   "holding": "Argenx SE ADR",
   "ticker": "ARGX",
   "weight_pct": 3.97,
   "page": "https://etfiq.com/holdings/argx/"
  },
  {
   "rank": 7,
   "holding": "Scholar Rock Holding",
   "ticker": "SRRK",
   "weight_pct": 3.73,
   "page": "https://etfiq.com/holdings/srrk/"
  },
  {
   "rank": 8,
   "holding": "Supernus Pharmaceuticals",
   "ticker": "SUPN",
   "weight_pct": 3.68,
   "page": "https://etfiq.com/holdings/supn/"
  },
  {
   "rank": 9,
   "holding": "Dianthus Therapeutics Inc",
   "ticker": "DNTH",
   "weight_pct": 3.65,
   "page": "https://etfiq.com/holdings/dnth/"
  },
  {
   "rank": 10,
   "holding": "Praxis Precision Medicines",
   "ticker": "PRAX",
   "weight_pct": 3.52,
   "page": "https://etfiq.com/holdings/prax/"
  },
  {
   "rank": 11,
   "holding": "Acadia Pharmaceuticals",
   "ticker": "ACAD",
   "weight_pct": 3.38,
   "page": "https://etfiq.com/holdings/acad/"
  },
  {
   "rank": 12,
   "holding": "SK Biopharmaceuticals Ltd",
   "ticker": null,
   "weight_pct": 3.31,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Dyne Therapeutics",
   "ticker": "DYN",
   "weight_pct": 3.21,
   "page": "https://etfiq.com/holdings/dyn/"
  },
  {
   "rank": 14,
   "holding": "Axogen",
   "ticker": "AXGN",
   "weight_pct": 3.04,
   "page": "https://etfiq.com/holdings/axgn/"
  },
  {
   "rank": 15,
   "holding": "H. Lundbeck Class B",
   "ticker": null,
   "weight_pct": 3.03,
   "page": null
  },
  {
   "rank": 16,
   "holding": "Xenon Pharmaceuticals",
   "ticker": "XENE",
   "weight_pct": 2.93,
   "page": null
  },
  {
   "rank": 17,
   "holding": "Sarepta Therapeutics",
   "ticker": "SRPT",
   "weight_pct": 2.68,
   "page": "https://etfiq.com/holdings/srpt/"
  },
  {
   "rank": 18,
   "holding": "Neuren Pharmaceuticals",
   "ticker": "NEU",
   "weight_pct": 2.42,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Biohaven",
   "ticker": "BHVN",
   "weight_pct": 2.36,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Bioarctic Class B",
   "ticker": null,
   "weight_pct": 1.98,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Taysha Gene Therapies",
   "ticker": "TSHA",
   "weight_pct": 1.52,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Oncolys Biopharma Inc",
   "ticker": null,
   "weight_pct": 1.5,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Integra Lifesciences Holdings",
   "ticker": "IART",
   "weight_pct": 1.48,
   "page": "https://etfiq.com/holdings/iart/"
  },
  {
   "rank": 24,
   "holding": "LB Pharmaceuticals Inc",
   "ticker": "LBRX",
   "weight_pct": 1.48,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Idorsia N Ltd",
   "ticker": "IDIA",
   "weight_pct": 1.46,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "BLK Csh Fnd Treasury Sl Agency",
   "weight_pct": 0.13
  },
  {
   "holding": "Cash Collateral Usd Sgaft",
   "weight_pct": 0.03
  },
  {
   "holding": "AUD Cash",
   "weight_pct": 0.02
  },
  {
   "holding": "KRW Cash",
   "weight_pct": 0.02
  },
  {
   "holding": "JPY Cash",
   "weight_pct": 0.02
  },
  {
   "holding": "EUR Cash",
   "weight_pct": 0.01
  },
  {
   "holding": "CHF Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "DKK Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "HKD Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "SEK Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "USD Cash",
   "weight_pct": -0.07
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.01
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/ibrn/holdings/ibrn-holdings.csv",
 "json_book": "https://etfiq.com/data/books/ibrn.json",
 "markdown": "https://etfiq.com/funds/ibrn/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of IBRN, data as of Oct 13, 2026. https://etfiq.com/funds/ibrn/holdings/"
}